Osaka, Japan

Hirohisa Shindo

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hirohisa Shindo: Innovator in Psychotropic Compounds

Introduction

Hirohisa Shindo is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of psychotropic compounds, showcasing his expertise through his innovative patents. His work has implications in various applications, particularly in the pharmaceutical industry.

Latest Patents

Hirohisa Shindo holds a patent for a compound titled "Pyrazolo[4,3-c]quinoline-3-one and imidazo[4,3-c]cinnolin-3-one." This patent describes compounds of the formula (I), where R¹ and R² can be hydrogen, alkyl, alkoxycarbonyl, carboxy, halogen, nitro, or trifluoromethyl. The compounds exhibit potent psychotropic activity, making them valuable in therapeutic contexts.

Career Highlights

Shindo is associated with Shionogi Company Limited, a prominent player in the pharmaceutical sector. His work at Shionogi has allowed him to focus on the development of innovative compounds that address various health challenges. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Hirohisa Shindo has collaborated with esteemed colleagues, including Takashi Sasatani and Akira Matsushita. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.

Conclusion

Hirohisa Shindo's contributions to the field of psychotropic compounds highlight his role as an influential inventor. His patent work and collaborations reflect his commitment to advancing pharmaceutical science. His innovative spirit continues to inspire future developments in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…